TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29084137

Group type: EXPERIMENTAL
Intervention: WB+KF
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: WB+guar gum+KF
Number of subjects: 20

Group type: COMPARATOR
Intervention: WB+KFsug
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: WB+guar gum+KFsug
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: KF
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: guar
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: KF+guar
Number of subjects: 20
Study: 25220110

Group type: EXPERIMENTAL
Intervention: Sustained natural apophyseal glides (SNAGs) with self‐SNAGs (n = 29)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Passive joint mobilisations (PJM) with range‐of‐motion (ROM) exercises (n = 29)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo (n = 28)
Number of subjects: 86
Study: 24671461

Group type: EXPERIMENTAL
Intervention: LigaSure Small Jaw® (LSJ)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Harmonic Focus® (HF)
Number of subjects: 126
Study: 22906730

Group type: EXPERIMENTAL
Intervention: Red wine (RW) consumption
Number of subjects: 0

Group type: COMPARATOR
Intervention: Grape extract (GE) tablets
Number of subjects: 0
Study: 19863450

Group type: EXPERIMENTAL
Intervention: Glycerol monolaurate (GML) in tampons
Number of subjects: 225

Group type: COMPARATOR
Intervention: Tampons without GML
Number of subjects: 225

Group type: COMPARATOR
Intervention: Women's own tampons
Number of subjects: 225
Study: 19151458

Group type: EXPERIMENTAL
Intervention: 0.02 mg/kg intravenous midazolam
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Intramuscular injection of 5mg diazepam + 25 mg promethazine
Number of subjects: 151

Group type: COMPARATOR
Intervention: 2cc of intravenous normal saline solution
Number of subjects: 151
Study: 15083485

Group type: EXPERIMENTAL
Intervention: Skewed parametric distributions (normal, gamma, log-normal, log-logistic)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Models that fit badly
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Different parametric models that fit the data equally well
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Choice of statistical model
Number of subjects: 0
Study: 11388472

Group type: EXPERIMENTAL
Intervention: MBP (40 mg per day)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 9554821

Group type: EXPERIMENTAL
Intervention: Calcium acetate
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Calcium carbonate suspension
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Aluminum phosphate binders
Number of subjects: 6
Study: 7985935

Group type: EXPERIMENTAL
Intervention: Synchronized combination of plasmapheresis followed by pulse cyclophosphamide (Ctx)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Pulse cyclophosphamide (Ctx) alone
Number of subjects: 14
Study: 2688530

Group type: EXPERIMENTAL
Intervention: Iopromide 300
Number of subjects: 31

Group type: COMPARATOR
Intervention: Ioxaglate 320 mgI/ml
Number of subjects: 31
Study: 1048183

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP/SMX) 10 mg TMP and 50 mg SMX/KG/day orally in two divided doses
Number of subjects: 65

Group type: COMPARATOR
Intervention: Ampicillin 100 mg/kg/day orally in four divided doses
Number of subjects: 65
Study: 31973936

Group type: EXPERIMENTAL
Intervention: Vd + daratumumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vd
Number of subjects: 0
Study: 31088176

Group type: EXPERIMENTAL
Intervention: anthocyanin-rich fruit juice
Number of subjects: 57

Group type: COMPARATOR
Intervention: placebo beverage (rich in vitamin C)
Number of subjects: 57
Study: 28481050

Group type: EXPERIMENTAL
Intervention: Bifocal treatment of myopia (3-year duration)
Number of subjects: 102
Study: 25835731

Group type: EXPERIMENTAL
Intervention: Motivational Plus Family Weight Loss (M + FWL)
Number of subjects: 520

Group type: COMPARATOR
Intervention: Comprehensive Health Education Program (CHE)
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: 8-week on-line tailored intervention
Number of subjects: 520

Group type: COMPARATOR
Intervention: Control on-line program
Number of subjects: 520
Study: 23072502

Group type: EXPERIMENTAL
Intervention: Parental intervention (joint observation method and infant massage)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard support group
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Parental intervention
Number of subjects: 42
Study: 21497049

Group type: EXPERIMENTAL
Intervention: Simultaneous bilateral cataract surgery (1 session)
Number of subjects: 520

Group type: COMPARATOR
Intervention: Sequential bilateral cataract surgery (2 sessions, 4 to 6 weeks apart)
Number of subjects: 520
Study: 19332969

Group type: EXPERIMENTAL
Intervention: GanedenBC30 (Bacillus coagulans GBI‐30, 6086)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (baseline measurements)
Number of subjects: 10
Study: 16933312

Group type: EXPERIMENTAL
Intervention: Thyroidectomy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Breast surgery
Number of subjects: 100
Study: 15257743

Group type: EXPERIMENTAL
Intervention: Scaling and root planing + subgingival administration of 10% doxycycline hyclate gel
Number of subjects: 11

Group type: COMPARATOR
Intervention: Scaling and root planing + subgingival placebo gel
Number of subjects: 11
Study: 11197756

Group type: EXPERIMENTAL
Intervention: Granisetron
Number of subjects: 16

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 16
Study: 9059950

Group type: EXPERIMENTAL
Intervention: Magnetic resonance velocity mapping
Number of subjects: 8

Group type: COMPARATOR
Intervention: Echo-Doppler measurements
Number of subjects: 8
Study: 7871035

Group type: EXPERIMENTAL
Intervention: CP-88,059-1 (2 mg to 60 mg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 3526592

Group type: EXPERIMENTAL
Intervention: Piperacillin
Number of subjects: 74

Group type: COMPARATOR
Intervention: Clindamycin plus Gentamicin
Number of subjects: 74
Study: 31311524

Group type: EXPERIMENTAL
Intervention: Side lying during nebulisation
Number of subjects: 39
Study: 27179107

Group type: EXPERIMENTAL
Intervention: Domperidone plus omeprazole
Number of subjects: 80

Group type: COMPARATOR
Intervention: Algycon plus omeprazole
Number of subjects: 80
Study: 25304986

Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity (MVPA)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Light-intensity physical activity
Number of subjects: 136
Study: 23733720

Group type: EXPERIMENTAL
Intervention: Tailored, multidisciplinary supportive care programme (two sessions at treatment commencement and completion, including needs assessment, active listening, self-care education)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 108
Study: 21858267

Group type: EXPERIMENTAL
Intervention: Herbal drug (combination of primrose, gentian root, vervain, elder flowers, and sorrel: Sinupret)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19117801

Group type: EXPERIMENTAL
Intervention: TEG-based management
Number of subjects: 69

Group type: COMPARATOR
Intervention: Physician directed product administration
Number of subjects: 69
Study: 17102916

Group type: EXPERIMENTAL
Intervention: Cuffed ePTFE graft (Venaflo)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Non-cuffed standard ePTFE graft (Gore-Tex)
Number of subjects: 36
Study: 15497388

Group type: EXPERIMENTAL
Intervention: Bio‐Pump (Medtronic)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Revolution (Cobe)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 20
Study: 11302353

Group type: EXPERIMENTAL
Intervention: Writing about a positive future
Number of subjects: 40

Group type: COMPARATOR
Intervention: No-writing control group
Number of subjects: 40
Study: 9145738

Group type: EXPERIMENTAL
Intervention: Intravenous ofloxacin followed by oral ofloxacin for 14-28 days
Number of subjects: 108

Group type: COMPARATOR
Intervention: Intravenous ampicillin/sulbactam followed by oral amoxicillin/clavulanate for 14-28 days
Number of subjects: 108
Study: 7893571

Group type: EXPERIMENTAL
Intervention: Bioelectrical impedance analysis (body resistance: R)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Plicometry (triceps, biceps, subscapular, and suprailiac skinfolds)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Plicometrically‐determined FM% and FFM‐Kg
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Prediction formulas for plicometric FM and FFM from body resistance and anthropometric variables
Number of subjects: 102
Study: 3250315

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Nisoldipine
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Tiapamil
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 76
Study: 31923472

Group type: EXPERIMENTAL
Intervention: CareAvenue - an automated e-health tool that screens for unmet social risk factors and informs and activates individuals to connect to resources and engage in self-care (15-20 min web-based program with routine follow-up).
Number of subjects: 720

Group type: COMPARATOR
Intervention: Standard care - receipt of contact information for existing health system assistance services.
Number of subjects: 720
Study: 30287671

Group type: EXPERIMENTAL
Intervention: Glimepiride + Linagliptin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glimepiride + Placebo
Number of subjects: 0
Study: 26883283

Group type: EXPERIMENTAL
Intervention: DISCOVER intervention (open-access psychological workshops using CBT methods, delivered in a 1-day workshop with additional telephone support)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 0
Study: 25153961

Group type: EXPERIMENTAL
Intervention: Two-factor model of the Foreign Language Classroom Anxiety Scale (FLCAS)
Number of subjects: 461
Study: 22166471

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate (LDX) 30 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate (LDX) 50 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate (LDX) 70 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 20683455

Group type: EXPERIMENTAL
Intervention: High iron and vitamin B(12) fortification (100% RDA)
Number of subjects: 543

Group type: EXPERIMENTAL
Intervention: Low iron and vitamin B(12) fortification (15% RDA)
Number of subjects: 543

Group type: COMPARATOR
Intervention: Control group (without H. pylori infection)
Number of subjects: 543
Study: 18461016

Group type: EXPERIMENTAL
Intervention: Valacyclovir 1 g once daily for 24 weeks
Number of subjects: 384

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 384
Study: 15938885

Group type: EXPERIMENTAL
Intervention: TMJ pain treatment
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control (no TMJ treatment)
Number of subjects: 51
Study: 11436967

Group type: EXPERIMENTAL
Intervention: Aqueous cluster VIT
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Aqueous rush VIT
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Depot cluster VIT
Number of subjects: 55
Study: 9564194

Group type: EXPERIMENTAL
Intervention: Interrater reliability training sessions for the 17-item Hamilton Depression Rating Scale
Number of subjects: 0
Study: 7996803

Group type: EXPERIMENTAL
Intervention: Dialysis fluid with 10 mmol/liter glucose (GD)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Dialysis fluid without glucose (GFD)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Dialysis fluid with glucose (GD)
Number of subjects: 8
Study: 3046553

Group type: EXPERIMENTAL
Intervention: Clozapine (up to 900 mg/d)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Chlorpromazine (up to 1800 mg/d)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 268

Group type: COMPARATOR
Intervention: Chlorpromazine
Number of subjects: 268
Study: 31396815

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Electronic pill bottles for medication adherence monitoring
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Bidirectional text messaging for medication adherence monitoring
Number of subjects: 149
Study: 27738832

Group type: EXPERIMENTAL
Intervention: Atorvastatin emulgel (2%)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 23435032

Group type: EXPERIMENTAL
Intervention: 0.01% 17β‐estradiol gel (n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 4% genistein gel (n = 15)
Number of subjects: 30
Study: 21912122

Group type: EXPERIMENTAL
Intervention: B‐type natriuretic peptide‐32 (BNP‐32)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: C‐reactive protein (CRP)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Endothelin‐1 (ET‐1)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Interleukin‐6 (IL‐6)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Tissue plasminogen activator (TPA)
Number of subjects: 112
Study: 19052054

Group type: EXPERIMENTAL
Intervention: Nebulised ipratropium bromide 500 microg (IB)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 17073895

Group type: EXPERIMENTAL
Intervention: Cataract surgery
Number of subjects: 45
Study: 14980929

Group type: COMPARATOR
Intervention: Diazepam 10 mg orally (DiazG)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Clonidine 150 microg intrathecally (Clon(i/t)G)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Clonidine 150 microg orally (Clon(p/o)G)
Number of subjects: 45
Study: 11260571

Group type: EXPERIMENTAL
Intervention: Art therapy (AT)
Number of subjects: 32
Study: 9773865

Group type: EXPERIMENTAL
Intervention: Daily ganciclovir
Number of subjects: 72

Group type: COMPARATOR
Intervention: 3-times-weekly ganciclovir
Number of subjects: 72
Study: 8148356

Group type: COMPARATOR
Intervention: 0 eggs per day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1 egg per day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 2 eggs per day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 4 eggs per day
Number of subjects: 20
Study: 2607293

Group type: EXPERIMENTAL
Intervention: High-temperature thermoplasticized gutta-percha
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: High copper amalgam
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Warm gutta-percha
Number of subjects: 45

Group type: COMPARATOR
Intervention: Negative control (no leakage)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Positive control (complete leakage)
Number of subjects: 45
Study: 31353158

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 24
Study: 30655509

Group type: EXPERIMENTAL
Intervention: Second-generation antipsychotic drug amisulpride
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: C1A subtype
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Predictive model
Number of subjects: 325
Study: 26948303

Group type: EXPERIMENTAL
Intervention: Protocol for early detection of symptoms and advanced care planning structured protocol for acute decompensations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Parallel and historical cohort for comparison
Number of subjects: 0
Study: 25130768

Group type: EXPERIMENTAL
Intervention: Hot moisturizing formulation
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Cold moisturizing formulation
Number of subjects: 18

Group type: COMPARATOR
Intervention: Both formulations
Number of subjects: 18
Study: 22476964

Group type: COMPARATOR
Intervention: Northern European patients starting hemodialysis with a catheter for vascular access (23%)
Number of subjects: 647

Group type: COMPARATOR
Intervention: Southern European patients
Number of subjects: 647

Group type: COMPARATOR
Intervention: Northern European patients (adjusted for age, sex, membrane permeability, comorbidity index, vascular access)
Number of subjects: 647
Study: 21851166

Group type: EXPERIMENTAL
Intervention: Timolol-brimonidine fixed combination (BTFC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Timolol-dorzolamide fixed combination (DTFC)
Number of subjects: 60
Study: 19692842

Group type: EXPERIMENTAL
Intervention: T1 postcontrast (T1(Gd))
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: DeltaR1
Number of subjects: 30

Group type: COMPARATOR
Intervention: Reference cartilage T1 postcontrast
Number of subjects: 30

Group type: COMPARATOR
Intervention: Reference cartilage DeltaR1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Correlation between T1(Gd) and DeltaR1 for repair tissue
Number of subjects: 30

Group type: COMPARATOR
Intervention: Correlation between T1(Gd) and DeltaR1 for normal reference cartilage
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Early postoperative interval
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Middle postoperative interval
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Late postoperative interval
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comparison of cartilage repair tissue and reference cartilage
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Comparison of early follow-up and later postoperative groups for cartilage repair tissue
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Comparison between the 2 later follow-up groups of reparative cartilage
Number of subjects: 30
Study: 16200592

Group type: EXPERIMENTAL
Intervention: MRI at 3.0T with 1.0-mm partition thickness
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: MRI at 3.0T with 1.5-mm partition thickness
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: MRI at 1.5T with 1.5-mm partition thickness
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: MRI at 3.0T
Number of subjects: 30
Study: 14668608

Group type: EXPERIMENTAL
Intervention: Prone position for 10 days for 6 hrs/day
Number of subjects: 225
Study: 10529659

Group type: EXPERIMENTAL
Intervention: Moderately early dexamethasone group (14 days, total dose 4.75 mg/kg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Early dexamethasone group (7 days, total dose 2.38 mg/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (for both phases)
Number of subjects: 30
Study: 7571981

Group type: EXPERIMENTAL
Intervention: Helicobacter pylori gastritis
Number of subjects: 36

Group type: COMPARATOR
Intervention: No Helicobacter pylori infection
Number of subjects: 36
Study: 2694418

Group type: EXPERIMENTAL
Intervention: Theophylline (5, 10, and 15 mg/l)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Enprofylline (1.25, 2.5, and 3.75 mg/l)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 866904

Group type: EXPERIMENTAL
Intervention: 100 mg indomethacin
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 100 mg indomethacin with 10 mg diazepam
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 31759611

Group type: EXPERIMENTAL
Intervention: Accelerometer measurements at 1 Hz (in 1-s intervals) at the vertical axis
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Discriminant analysis
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Acceleration peaks
Number of subjects: 48
Study: 30345860

Group type: EXPERIMENTAL
Intervention: Psychological stress
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Physical stress
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control
Number of subjects: 21
Study: 28655793

Group type: EXPERIMENTAL
Intervention: Ipilimumab 10 mg/kg every 3 weeks for four doses, then 10 mg/kg every 12 weeks for up to 3 years
Number of subjects: 57

Group type: COMPARATOR
Intervention: Best Supportive Care (BSC)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Ipilimumab 10 mg/kg
Number of subjects: 57
Study: 25268656

Group type: EXPERIMENTAL
Intervention: Botulinum toxin + standardized self-rehabilitation programme (R group, n=19)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Botulinum toxin alone (C group, n=16)
Number of subjects: 35
Study: 23290205

Group type: EXPERIMENTAL
Intervention: E-BEHAVE-AD
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: NBRS
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: NPI
Number of subjects: 87

Group type: COMPARATOR
Intervention: E-BEHAVE-AD, NBRS, NPI
Number of subjects: 87
Study: 21375092

Group type: EXPERIMENTAL
Intervention: Intravenous ondansetron (2 ml, 4 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (2 ml)
Number of subjects: 60
Study: 18788503

Group type: EXPERIMENTAL
Intervention: Levobupivacaine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ropivacaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Racemic bupivacaine
Number of subjects: 0
Study: 16961773

Group type: EXPERIMENTAL
Intervention: Lo-Tact-1
Number of subjects: 40

Group type: COMPARATOR
Intervention: ATG
Number of subjects: 40
Study: 12767733

Group type: EXPERIMENTAL
Intervention: Topiramate (25-300 mg per day)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 11039967

Group type: EXPERIMENTAL
Intervention: Multifactorial home visits by a community nurse (5 visits over 1 year)
Number of subjects: 316

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 316
Study: 9109860

Group type: COMPARATOR
Intervention: cM-T412 (anti-CD4 antibody)
Number of subjects: 29
Study: 8258118

Group type: EXPERIMENTAL
Intervention: Perycit, 500 mg, tid, for 3 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Trental, 100 mg, tid, for 3 months
Number of subjects: 20
Study: 3996244

Group type: EXPERIMENTAL
Intervention: Class I antiarrhythmic agents
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 34
Study: 30064301

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional fractionated radiotherapy
Number of subjects: 0
Study: 28796528

Group type: EXPERIMENTAL
Intervention: Stretching
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (no stretching)
Number of subjects: 17
Study: 26790781

Group type: EXPERIMENTAL
Intervention: Circumpatellar electrocautery (denervation)
Number of subjects: 184

Group type: COMPARATOR
Intervention: No denervation (control)
Number of subjects: 184
Study: 23467055

Group type: EXPERIMENTAL
Intervention: 40% urea ointment with plastic dressing
Number of subjects: 105

Group type: COMPARATOR
Intervention: bifonazole-urea ointment
Number of subjects: 105